History of scurvy and use of vitamin C in critical illness: A narrative review
Please always quote using this URN: urn:nbn:de:bvb:20-opus-318176
- In 1747, an important milestone in the history of clinical research was set, as the Scottish surgeon James Lind conducted the first randomized controlled trial. Lind was interested in scurvy, a severe vitamin C deficiency which caused the death of thousands of British seamen. He found that a dietary intervention with oranges and lemons, which are rich in vitamin C by nature, was effective to recover from scurvy. Because of its antioxidative properties and involvement in many biochemical processes, the essential micronutrient vitamin C plays aIn 1747, an important milestone in the history of clinical research was set, as the Scottish surgeon James Lind conducted the first randomized controlled trial. Lind was interested in scurvy, a severe vitamin C deficiency which caused the death of thousands of British seamen. He found that a dietary intervention with oranges and lemons, which are rich in vitamin C by nature, was effective to recover from scurvy. Because of its antioxidative properties and involvement in many biochemical processes, the essential micronutrient vitamin C plays a key role in the human biology. Moreover, the use of vitamin C in critical illness—a condition also resulting in death of thousands in the 21st century—has gained increasing interest, as it may restore vascular responsiveness to vasoactive agents, ameliorate microcirculatory blood flow, preserve endothelial barriers, augment bacterial defense, and prevent apoptosis. Because of its redox potential and powerful antioxidant capacity, vitamin C represents an inexpensive and safe antioxidant, with the potential to modify the inflammatory cascade and improve clinical outcomes of critically ill patients. This narrative review aims to update and provide an overview on the role of vitamin C in the human biology and in critically ill patients, and to summarize current evidence on the use of vitamin C in diverse populations of critically ill patients, in specific focusing on patients with sepsis and coronavirus disease 2019.…
Author: | Ellen Dresen, Zheng-Yii Lee, Aileen Hill, Quirin Notz, Jayshil J. Patel, Christian Stoppe |
---|---|
URN: | urn:nbn:de:bvb:20-opus-318176 |
Document Type: | Journal article |
Faculties: | Medizinische Fakultät / Klinik und Poliklinik für Anästhesiologie (ab 2004) |
Language: | English |
Parent Title (English): | Nutrition in Clinical Practice |
Year of Completion: | 2023 |
Volume: | 38 |
Issue: | 1 |
First Page: | 46 |
Last Page: | 54 |
Source: | Nutrition in Clinical Practice 2023, 38(1):46-54. DOI: 10.1002/ncp.10914 |
DOI: | https://doi.org/10.1002/ncp.10914 |
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
Tag: | COVID‐19; antioxidant; critical illness; scurvy; sepsis; vitamin C |
Release Date: | 2023/07/04 |
Licence (German): | CC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International |